Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer

BACKGROUND: SCALOP, a randomised, phase II trial, tested the activity and safety of gemcitabine (GEM)-based and capecitabine (CAP)-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC). Here we present the long-term outcomes. METHODS: Eligibility: histologically proven LAPC ⩽7 cm....

Descripción completa

Detalles Bibliográficos
Autores principales: Hurt, C N, Falk, S, Crosby, T, McDonald, A, Ray, R, Joseph, G, Staffurth, J, Abrams, R A, Griffiths, G, Maughan, T, Mukherjee, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482737/
https://www.ncbi.nlm.nih.gov/pubmed/28376080
http://dx.doi.org/10.1038/bjc.2017.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482737/
https://www.ncbi.nlm.nih.gov/pubmed/28376080
http://dx.doi.org/10.1038/bjc.2017.95

Ejemplares similares